Protocol summary

Study aim
Comparison of success rate of AGV surgery with and without Adjunctive 5-fluorouracil treatment in patients with neovascular glaucoma
Design
Clinical trial study with two parallel groups, randomized using computer permuted block randomization, 35 patients in each group are included and followed up for at least 6 months.
Settings and conduct
This study will be performed on patients with neovascular glaucoma requiring shunt surgery who are referred to the glaucoma clinic of Rasoul Akram Hospital. Patients after randomization are divided into two groups. In the shunt surgery group alone, Ahmed shunt implanted in the superotemporal area at a distance of 10 mm from the limbus. In the shunt surgery with 5FU injection group, In addition to the shunt implantation in the previous method, 5FU is injected in the first, third and fifth weeks of follow-up. Patients are then examined regularly to evaluate the success and complications of treatment.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Patients with neovascular glaucoma who require implant Ahmed shunt to control ocular pressure. Exclusion criteria: No Light Perception patients, age less than 18 years, history of any type of eye surgery including previous glaucoma and retinal surgeries (except uncomplicated cataract surgery), history of cyclodestructive procedures, pregnant patients.
Intervention groups
Patients with neovascular glaucoma are divided into two groups. In one group, patients underwent Ahmed shunt surgery and in the other group, patients underwent Ahmed shunt surgery with 5FU injection.
Main outcome variables
Success rate, incidence of hypertensive phase, complications, intraocular pressure before and after surgery, number of medication used before and after surgery.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20210901052357N2
Registration date: 2022-05-23, 1401/03/02
Registration timing: registered_while_recruiting

Last update: 2022-05-23, 1401/03/02
Update count: 0
Registration date
2022-05-23, 1401/03/02
Registrant information
Name
Farhad Najafzadeh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 6694 5106
Email address
najafzadeh.farhad@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-01-26, 1400/11/06
Expected recruitment end date
2023-01-26, 1401/11/06
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effect of subconjunctival 5-fluorouracil on the outcome of Ahmed valve in neovascular glaucoma: Randomized Clinical Trial
Public title
Subconjunctival 5-fluorouracil on the outcome of Ahmed valve in neovascular glaucoma
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with neovascular glaucoma Lack of eye pressure control with medication
Exclusion criteria:
Patients with other types of glaucoma
Age
From 18 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 70
Randomization (investigator's opinion)
Randomized
Randomization description
For randomization, we will use the random block method so that the number of samples in the two groups is the same. The blocks are considered as 4, with a and b representing the two study groups. All possible permutations for a block of 4 are as follows: aabb, abba, abab, bbaa, baab, baba. From these 6 permutations, one block will be selected at a simple random time. The reason for this is to reduce the likelihood that final allocations will be predictable. After selecting the block, the person will be assigned to group a or b in the same way.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Rasoul Akram Hospital, Maziar Mansouri St., Sattar Khan St.
City
Tehran
Province
Tehran
Postal code
14456131310
Approval date
2022-01-25, 1400/11/05
Ethics committee reference number
IR.IUMS.REC.1400.1009

Health conditions studied

1

Description of health condition studied
neovascular glaucoma
ICD-10 code
H40
ICD-10 code description
Glaucoma

Primary outcomes

1

Description
Intraocular pressure (IOP)
Timepoint
Before surgery, first day, first week, third week, fifth week, third month, sixth month after surgeryا
Method of measurement
Intraocular pressure is measured with a Goldmann Applanation Tonometer (GAT).

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group:Patients with neovascular glaucoma undergoing shunt implant surgery with during surgery. This method will use Ahmad FP7 model valved shunt (New World Medical, LA), which is one of the most commonly used shunts in the world. First, Mitomycin C at a dose of 0.04% is placed in the shunt plate for two minutes and then rinsed. The shunt is fixed and then the shunt tube is inserted into the eye and fixed with nylon 10.0 thread. The conjunctiva is also swabbed with 8.0 vicryl sutures. After the operation, patients undergo regular examinations according to a specific protocol to evaluate the effectiveness as well as possible complications.
Category
Treatment - Surgery

2

Description
Intervention group: Patients with neovascular glaucoma undergoing shunt implant surgery with 5FU during and after surgery .This method will use Ahmad FP7 model valved shunt (New World Medical, LA), which is one of the most commonly used shunts in the world. First, Mitomycin C at a dose of 0.04% is placed in the shunt plate for two minutes and then rinsed. The shunt is fixed and then the shunt tube is inserted into the eye and fixed with nylon 10.0 thread. The conjunctiva is also swabbed with 8.0 vicryl sutures. After the operation, patients undergo regular examinations according to a specific protocol to evaluate the effectiveness as well as possible complications. Also in the first, third and fifth weeks, 5FU injections are given as a subconjugate with a volume of 0.1 ml containing 5 mg of the drug.
Category
Treatment - Surgery

Recruitment centers

1

Recruitment center
Name of recruitment center
Glaucoma clinic of Rasoul Akram Hospital in Tehran
Full name of responsible person
Farhad Najafzadeh
Street address
Rasoul Akram Hospital, Maziar Mansouri St., Sattarkhan St.
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2545
Fax
+98 21 6651 6999
Email
najafzadeh.farhad@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Abbas Motavallian
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8862 2703
Fax
+98 21 8670 2503
Email
najafzadeh.farhad@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Farhad Najafzadeh
Position
Glaucoma Fellowship Assistant
Latest degree
Specialist
Other areas of specialty/work
Ophthalmology
Street address
Rasoul Akram Hospital, Maziar Mansouri St., Sattar Khan St.
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6651 6999
Fax
Email
Najafzadeh.Farhad@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Arezoo Miraftabi
Position
Associate Professor
Latest degree
Subspecialist
Other areas of specialty/work
Ophthalmology
Street address
Rasoul Akram Hospital, Maziar Mansouri St., Sattar Khan St.
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6651 6999
Email
arezoomiraftabi@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Farhad Najafzadeh
Position
Non-faculty specialist physician
Latest degree
Specialist
Other areas of specialty/work
Ophthalmology
Street address
Rasoul Akram Hospital, Maziar Mansouri St., Sattar Khan St.
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6651 6999
Email
najafzadeh.farhad@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...